NCT07182110

Brief Summary

The transversus abdominis plane (TAP) block is widely used as part of analgesia for abdominal surgeries such as laparoscopic cholecystectomy. While bupivacaine is commonly used for TAP blocks with reported success. Dexamethasone is often used as an adjuvant in prolonging duration of blocks; however, data on its efficacy in enhancing TAP blocks in laparoscopic cholecystectomy remain limited. This study aims to assess whether adding dexamethasone to bupivacaine in a TAP block improves postoperative pain control and reduces opioid consumption

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for phase_1

Timeline
4mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Aug 2025Aug 2026

Study Start

First participant enrolled

August 19, 2025

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 11, 2025

Last Update Submit

September 11, 2025

Conditions

Keywords

Transversus AbdominisNerve BlockDexamethasonePainAcute PainPain ManagementBreakthrough PainAnalgesics, OpioidAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Time to first analgesic requirement (in hours)

    within 24 hours

Study Arms (2)

Marcaine

ACTIVE COMPARATOR
Drug: Marcaine- 0.25%

Marcaine and Dexamethasone

EXPERIMENTAL
Drug: Dexamethasone enhanced TAP Block

Interventions

20 ml Marcaine containing 0.25% bupivacaine + 4 mg dexamethasone + normal saline

Marcaine and Dexamethasone

20 ml solution containing 0.25% bupivacaine + normal saline

Marcaine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult Patients
  • Laparoscopic Cholecystectomy Patients
  • Patients able to consent

You may not qualify if:

  • Patients allergic to dexamethasone
  • Allergic to Marcaine
  • Hemodynamically unstable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Makassed General Hospital

Beirut, Lebanon

Location

Related Publications (4)

  • Ghani SA, Hussain HU, Wahid MA, Majeed N, Burney S, Tanveer A, Asghar MS. Laparoscopic-assisted versus ultrasound-guided transversus abdominis plane block for laparoscopic cholecystectomy: a systematic review and meta-analysis. BMC Surg. 2024 Dec 21;24(1):400. doi: 10.1186/s12893-024-02706-7.

    PMID: 39709396BACKGROUND
  • Uzunay NT, Mingir T, Erginoz E, Karakas DO, Kose E. Comparison of laparoscopic-guided versus ultrasound-guided TAP block in laparoscopic cholecystectomy. Cir Cir. 2024;92(2):174-180. doi: 10.24875/CIRU.23000394.

    PMID: 38782390BACKGROUND
  • Taheri P, Moinfar Z, Varpaei HA. Comparison of the Stress Responses After TAP Block and Epidural Anesthesia in Patients Undergoing Elective Laparoscopic Cholecystectomy Under General Anesthesia: Randomized Clinical Trial. Clin J Pain. 2023 Jul 1;39(7):319-325. doi: 10.1097/AJP.0000000000001117.

    PMID: 37083674BACKGROUND
  • Nair P, Behera CR, Patra RK, Shekar N, Rao LS, Pujari P, Panda B, Mishra A. Efficacy and Cost-Effectiveness of Laparoscopic Transversus Abdominis Plane (TAP) Block in Laparoscopic Cholecystectomy: A Comparison With the Non-TAP Group. Cureus. 2022 Nov 30;14(11):e32038. doi: 10.7759/cureus.32038. eCollection 2022 Nov.

    PMID: 36600856BACKGROUND

MeSH Terms

Conditions

PainAcute PainAgnosiaBreakthrough Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesia Attending

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 19, 2025

Study Start

August 19, 2025

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations